The Promise of Telemedicine for American Health

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
254
The Promise of Telemedicine for American Health Care

NetworkNewsWire Editorial Coverage: Although amazing advances unceasingly occur in drug development and medical procedures, delivery of health care services to patients has been woefully slow to embrace technology. It took a federal government mandate in 2014 to force health care providers to adopt and demonstrate “meaningful use” of electronic medical records (EMR) in order to maintain Medicare and Medicaid reimbursement levels. Since the mandate, the use of EMR’s has expanded worldwide, improving quality, safety and efficiencies throughout global health organizations. However, health care still, disturbingly, stands apart from all other industries in the efficient conveyance of patient services, which is most acutely felt among the 80+ million Americans that live in underserved rural areas. These regions suffer from a chronic shortage of primary care physicians and, even more critically, specialty care physicians. Urban-based health companies have little incentive to expand footprints into sparsely populated communities, and the promises that telemedicine would fill this critical void have fallen far short of expectations. This dilemma presents an enormous societal challenge, but, conversely, it presents an even greater opportunity for health care companies that provide operative solutions. In this space, Medical Innovation Holdings, Inc. (MIHI) (MIHI Profile) is rolling out a disruptive telemedicine business model that positions it among the ranks of larger peers. At the same time, MIHI’s approach greatly differentiates it from its peers, including Teladoc, Inc. (TDOC), eWellness Healthcare Corp. (EWLL), Evolent Health Inc. (EVH) and health care behemoth UnitedHealth Group Inc. (UNH).

The telemedicine market in the United States is forecast to exceed $13 billion by 2021, according to research and consulting firm Pharmaion (http://nnw.fm/Y7wSr). An aging population, the rising incidence of chronic diseases and spiraling health care costs are making telemedicine one of the fastest growing sectors in health care. Telemedicine includes multiple medical subspecialties, such as telepediatrics, teleradiology, telepsychiatry and telecardiology, though, often, these services are not being effectively delivered to the people that need them most.

By partnering with rural doctors and Affordable Care Organizations (ACOs), Medical Innovation Holdings (MIHI) has turned the moribund telemedicine business model on its head to provide access to previously inaccessible specialty medical services.

Traditional telemedicine companies charge a monthly online subscription fee to join a network to access doctors on demand. Patients using this business-to-consumer (B2C) service are forced into a symptom-based medical approach with limited treatment options, since the doctor has no immediate access to diagnostic tests or patient records. The patient is responsible for the monthly subscription fee, as well as doctor charges, because insurance isn’t accepted. Patients pay more, receive less and have no continuity of care. In essence, these companies are contract service providers that deliver virtual physician interfaces and not genuine medical practices.

This is where MIHI stands apart from its peers. Employing its unique business-to-business (B2B) and B2C models, MIHI connects virtual health specialty doctors with primary care physicians and their patients, reducing cost while enhancing quality of care. Upon partnership with primary care doctors, MIHI provides the necessary tools for expanded patient care and the opportunity for physicians to expand their businesses. MIHI gives the primary doctor a full tele-cart workstation with comprehensive peripherals. When a patient electronically interfaces with a specialist in the local doctor’s office, the specialist has immediate access to multiple diagnostic tests and patient records in order to determine an appropriate course of action based on evidentiary findings.

To provide rural clinics unmatched efficacy and set a new standard in the marketplace, Medical Innovation has entered into an exclusive manufacturing supply agreement for customized NextGen telemedicine equipment that will fit the footprint of any doctor’s office partnered with MIHI and support a blend of in-office and virtual visits (http://nnw.fm/2FeuN). The agreement with MDI Source, a 30-year veteran of the technology industry, will seamlessly couple MDI’s hardware with MIHI’s EMR/PMS software solution.

MIHI doesn’t charge a subscription fee like other telemedicine companies but rather readily accepts insurance, including Medicare, Medicaid and the Veterans Choice Program. The company’s mission is being embraced by the medical community. As indication, MIHI recently engaged a new ACO in Florida, and another, in Georgia, is ready to come aboard, opening the door to over 1,000 new doctors.

Substantially expanding its market reach, MIHI also recently announced the launch of Telemedicos USA (http://www.TelemedicosUSA.com), a Spanish-language health care platform positioned to address the needs of the 58 million Hispanics living in the United States. Telemedicos USA provides the opportunity for MIHI to deliver its specialty services to a significant market demographic and provide needed services for those who are more comfortable in the Spanish language.

“This was a natural evolution for us. We purposefully positioned MIHI for this market because we understand the nuances of providing services to such an ethnically diverse group that make up the Hispanic community,” MIHI CEO Jake Sanchez stated in the press release.

To effectively manage rapid national deployment and maximize operational opportunities, MIHI appointed Kevin Swint to the position of chief operating officer (http://nnw.fm/mGE9V). A 25-year veteran in operations and senior leadership experience in the health and wellness industry, Swint will contribute his wealth of knowledge in IT, retail, health care and executive management to support the company’s corporate vision. With tenures at Arthur Andersen, IDS Scheer, Canon Technology Solutions and IBM, Swint is also a certified professional in Healthcare Information and Management Systems (CPHIMS) and an active member of HIMSS.

“MIHI is well-positioned to drive new value for patients, providers and payers by increasing access to critical health and wellness services and products while seeking to bend the cost curve in pursuit of lower cost and improved outcomes for patients and their families,” Swint stated in the news release announcing his appointment.

MIHI is also developing ancillary products and services that synergistically blend with its mission. The company is negotiating the purchase of a recognized nutraceutical company, pursuing CBD hemp oil therapies for distribution and developing insurance programs to cover alternative medical therapeutics. All of these products and services will dovetail into MIHI’s nationwide network, providing discounts to consumers and added revenue streams to both MIHI and its local physician partners.

Using a subscription-based business-to-consumer model, Teladoc (TDOC) offers 24/7 access to U.S. primary care doctors and pediatricians. Patients receive symptom-based diagnoses when they use the service for non-emergency medical issues such as flu symptoms, ear infections or rashes. Insurance is not accepted, and, in addition to the subscription fee, patients are responsible for the doctor’s “encounter fee.” The fee the patient pays is typically less than the physician charges Teladoc. This means that Teladoc makes up the difference from its subscription revenue. Early in the telemedicine industry, the company has 11.5 million members and will likely be challenged to achieve its goal of profitability by 2018. With an all-time high of $37.55, Teladoc is trading around $32 per share. The stock surged 100% over the last year, carries a market capitalization of $1.8 billion and has a -20.77 P/E.

Physical therapy focused, eWellness Healthcare (EWLL) offers insurance reimbursable real-time distance-monitored treatments. The company’s business model centers on licensing its PHZIO platform to physical therapy clinics across the U.S. and also as a monitored corporate wellness program. The company is developing marketing channel partnerships with industry association members, existing software-based telemedicine providers and physical therapy billing and practice management providers. Due to its real-time patient monitoring feature, the PHZIO platform is insurance reimbursable. The company has a market cap of $17.3 million, losing $0.24 per share, and a price earnings ratio of -55.

Evolent Health (EVH) supports health systems and physician organizations in their migration toward value-based care, rewarding health care providers with incentive payments for the quality of care they give. Evolent provides an end-to-end, technology-enabled services platform for providers that processes and integrates services and enables providers to migrate their economic orientation from fee-for-service reimbursement to models that reward value-based payment models. The stock trades around $17 a share, down from its 52-week high of $27.50. The company has a $1.3 billion market cap and a -13.94 P/E.

The obvious elephant in the industry, UnitedHealth Group (UNH) operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum. NowClinic, an Internet-based service of OptumHealth, allows consumers to select and interact with independent health care providers. Enrollment is free, and patients pay for 10-minute visits via credit card. Providing what may be deemed only peripheral primary care, NowClinic collects payment, keeps a portion and pays the doctor. There’s no continuity of care, as doctors set available hours and choose to accept or decline patient visits. Trading at all-time highs around $210, UNH has a market cap of just over $200 billion.

Telemedicine has been around in varying incarnations for nearly 20 years, yet millions of citizens still suffer with little to no critical care. History has shown preceding business models to be self-serving top-down systems that never really practiced community-based medicine. Only through the intelligent integration of telecommunications, information technology and local community-based care will telemedicine genuinely deliver on its long-standing promise. Far flung communities will then be healthier, and the companies that deliver on that promise will be amply rewarded.

For more information on Medical Innovation Holdings visit Medical Innovation Holdings, Inc. (MIHI)

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Medical Innovation Holdings Inc (MIHI) Stock Research Links

MIHI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mather Promotes Connection with Free Gardening Kits

Updated Category News Views 37

Winter Loneliness No Match for Mather’s Green Thumb Initiative Here's something heartfelt coming out of the Windy City: gardening kits. This ain't your standard Wall Street babble—it's about a nonprofit called Mather trying to shed some light on the colder months by giving seniors in Illinois a damn good reason to be joyfully busy. No boilersuit and tie needed, just a...

Continue Reading
TI's Agentic AI Boosts CCStudio for Faster Development

Updated Category News Views 73

Agentic Abilities: The Future of Embedded Development? If you think embedded development couldn't get snappier, Texas Instruments (TI) might just make you rethink that. They're ramping up their CCStudio ecosystem with some solid AI muscle, transforming the way engineers tackle embedded software tasks. This isn't your typical AI chatter—it's about chopping down...

Continue Reading
Mass-Vac Unleashes Advanced Vacuum Protection

Updated Category News Views 92

Introducing a Heavy-Duty Defender for Lab Systems When it comes to safeguarding central laboratory vacuum systems, you can bet there’s more at play than meets the eye. Mass-Vac, Inc., steps up and doesn't mess around with their latest innovation—the MV Multi-Trap® Vacuum Inlet Trap. Climbing aboard in November 2026, this stout guardian against contamination is out to...

Continue Reading
Tigermed's Strategic Shift: Privatization and Divestment

Updated Category News Views 98

Hang onto your hats, folks, because Tigermed is shaking things up in a big way. The Chinese juggernaut you might know as Hangzhou Tigermed Consulting Co., Ltd. is throwing its hat in the ring for the privatization of Frontage Holdings. But that's not the end of the story—there's a whole restructuring circus coming to town, and they've got big plans to offload some...

Continue Reading
Sokolove Law Wins $28.8M Verdict for Misdiagnosis Case

Updated Category News Views 71

Jury Awards $28.8 Million in Misdiagnosis Case Well, here's a tale that's bound to ruffle some feathers in the medical community—$28.8 million tossed on the table because an emergency room missed a life-threatening aortic aneurysm. For the uninitiated, this isn't just chump change; it's the cost of dropping the ball when the stakes are as high as a human life. A jury in...

Continue Reading
Li-Fire Tackles E-Bike Battery Fires Head-On

Updated Category News Views 52

E-Bike Enthusiasm Meets Dangerous Fire Risks Imagine this: your sleek new e-bike, your pride and joy, becomes a ticking time bomb. That's the reality facing more folks than we'd like these days, as e-bike battery fires surge across the globe. Amidst the holiday hustle, Li-Fire hits the scene with a lifeline—a free replacement program for their E-bike Lithium Fire Cover....

Continue Reading
CMC's CFO Shift: Kenji Hashimoto Steps In

Updated Category News Views 36

CMC's Strategic Financial Transition In the sometimes wild world of business, changes at the top can send ripples through an organization like a hammer strike on a steel pipe. CMC, known for its construction solutions, has announced just such a change with its chief financial officer. Paul Lawrence, the financial hand on the tiller since 2019, is hopping off the boat come...

Continue Reading
First Graphene Taps Deeper into US Defense Market

Updated Category News Views 128

Graphene Making Waves in Defense Fresh off the press, folks. First Graphene Limited is struttin' onto the US defense scene with a repeat order for its PureGRAPH®—a big deal in the realm of electrically conductive inks. The tally comes to around A$35,000 in an order from a longtime American customer. We're talking about inks that print circuits, sensors, and more,...

Continue Reading
Lyric Health & VivaScore: Revolutionizing Care Integration

Updated Category News Views 29

Partnering for a Healthier Tomorrow Blood, sweat, and tears—health's never been for the faint of heart. Now, Lyric Health and VivaScore are teaming up to give healthcare a serious upgrade. They're not just pushing papers—these folks mean business with their brand-new strategic partnership. The synergy between the brains at VivaScore and the ecosystem that Lyric's...

Continue Reading
Kelley Blue Book Hits 100: Celebrating on Route 66

Updated Category News Views 60

If you've ever punched numbers on car values, you've probably bumped into Kelley Blue Book. This icon in vehicle valuation is marking its 100th birthday with a bang—road-tripping across Route 66 to sprinkle some joy across the dusty roads of history. Nostalgia Meets the Open Road The legendary Route 66 is not just the backdrop but the beating heart of this centennial...

Continue Reading

Top 5 Most Recently Viewed Articles

NYU Langone Health Sets the Standard for Transplant Excellence

Updated Category News Views 219

Leading the Way in Transplant Excellence NYU Langone Health has established itself as a premier health institution, particularly noted for its outstanding kidney, liver, and lung transplant programs. The dedication to providing top-tier care is evident in the consistently high quality outcomes reported by the NYU Langone Transplant Institute. This institute is known for...

Continue Reading
Dollar Tree's Unusual Options Activity Highlights Key Trends

Updated Category News Views 173

Understanding Dollar Tree's Recent Options Trends Investors are witnessing a notable shift toward a bullish stance on Dollar Tree, indicating that significant developments could be on the horizon. This emerging interest from well-capitalized investors is critical for market players to consider. Recent observations of the options landscape show that this isn't merely...

Continue Reading
PNC Financial Services: Short Interest Rising, What’s Next?

Updated Category News Views 290

Short Interest Surge: A Red Flag or Opportunity? Short interest isn't just a bunch of numbers drizzled over your trading screen; it's cold, hard emotion boiling beneath the surface. When it comes to PNC Financial Services Group Inc (NYSE:PNC), we're staring at a 13.24% spike since the last report, amounting to a whopping 6.22 million shares sold short. That’s a mere...

Continue Reading
Exciting Azazie Pop-Up Event in Los Angeles for Brides

Updated Category News Views 224

Azazie Brings a Unique Bridal Experience to Los Angeles Azazie, a renowned direct-to-consumer bridal and special occasion retailer, is thrilled to announce an exclusive one-day pop-up event in Los Angeles. This pop-up promises to be a delightful opportunity for brides-to-be, bridal parties, and fashion enthusiasts to explore a stunning collection of wedding gowns and...

Continue Reading
Biomea Fusion's Icovamenib Shines in Phase II Diabetes Study

Updated Category News Views 195

Positive Phase II Results for Icovamenib in Type 2 Diabetes Biomea Fusion, Inc., a clinical-stage company focused on innovative treatments for diabetes and obesity, recently shared encouraging findings from its Phase II COVALENT-111 study, which examined the effects of icovamenib in type 2 diabetes (T2D) patients. This pivotal research provides vital insights into the...

Continue Reading